NASDAQ:CEMI   Chembio Diagnostics, Inc
target is going to be this gap-fill once EUA news is released. We are about 91 days I believe. Once FDA approves we will have a great chance that this sees the gap fill. Big buyers stepping in, shorts covering.

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.